{"id":17201,"date":"2023-03-27T13:00:00","date_gmt":"2023-03-27T13:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4052898_CN52898_0"},"modified":"2023-03-27T13:00:00","modified_gmt":"2023-03-27T13:00:00","slug":"noul-co-ltd-the-right-foundation-commences-research-and-development-for-supporting-malaria-control","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=17201","title":{"rendered":"Noul Co. Ltd &#8211; The RIGHT Foundation Commences Research and Development for Supporting Malaria Control"},"content":{"rendered":"<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/1854227\/Noul_logo1_Logo.jpg?p=medium600\" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<ul type=\"disc\">\n<li>Aim to accelerate global business and access to the public market based on reliable research results<\/li>\n<li>Grant funds will be utilized for global clinical studies and cost-effectiveness analysis of the miLab\u2122&nbsp;Platform over the next three years<\/li>\n<\/ul>\n<p><span class=\"legendSpanClass\">YONGIN, <span class=\"xn-location\">South Korea<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">March 27, 2023<\/span><\/span> \/PRNewswire\/ &#8212; Noul Co. Ltd (CEO : <span class=\"xn-person\">David Lim<\/span>) announced that it has signed an agreement with The RIGHT Foundation to conduct a global clinical studies to determine the potential for public market access in malaria-endemic countries of <span class=\"xn-location\">Africa<\/span> and <span class=\"xn-location\">Asia<\/span>. Over the next three years, about <span class=\"xn-money\">four billion KRW<\/span> (<span class=\"xn-money\">3.1 million USD<\/span>) that Noul received from The RIGHT Foundation will be used to support global clinical studies and cost-effectiveness analysis of the miLab\u2122 Platform in <span class=\"xn-location\">Africa<\/span> and <span class=\"xn-location\">Asia<\/span>.<\/p>\n<p>To ensure the credibility of the result, Noul will collaborate with global institutions and national malaria programs such as PATH (Program for Appropriate Technology in Health), Swiss TPH (Swiss Tropical and Public Health Institute), GIDC (Ghana Infectious Disease Center), MNMCP(Malawi National Malaria Control Program) and <span class=\"xn-org\">University of Notre Dame<\/span> in the U.S.<\/p>\n<p>Malaria is a disease with a high demand for diagnosis, affecting more than 200 million people yearly. Still it has recently been facing great difficulties in diagnosis due to the increase of genetic mutations that are difficult to diagnose with existing RDT(rapid diagnostic tests), and drug resistance problem. Through this agreement, Noul and The RIGHT Foundation will conduct multi-country clinical studies to &nbsp;compare the diagnostic accuracy of the miLab\u2122 with the result of the gold standard microscopic diagnosis and PCR analysis. Also, both parties will analyze the value and cost-effectiveness of the miLab\u2122 Platform in the global healthcare market, and accelerate public market entry through local product registration.<\/p>\n<p><span class=\"xn-person\">David Lim<\/span>, CEO of Noul stated &#8220;Through this collaboration with The RIGHT Foundation, Noul will contribute to promoting global health equity and the next level of business performance based on internationally recognized references. We will continue to collaborate with various institutions worldwide to expand the miLab\u2122 Platform to become the global standard for microscopic diagnosis of malaria, which is performed over 200 million times a year.&#8221;<\/p>\n<p>The RIGHT Foundation is a global health research funding foundation through the public-private partnership between the Government of Korea, Korean Life Science companies, and Bill &amp; Melinda Gates Foundation (BMGF), to address the medical and technological needs towards alleviating the burden of infectious diseases especially in developing countries. It provides a platform to catalyze collaborations between Korean and international researchers, product developers and public health workers to develop essential health technologies as global public good with the ultimate goal of improving health and health equity globally.<\/p>\n<p>Noul&#8217;s miLab\u2122 diagnostic platform is an all-in-one blood diagnosis platform that combines cartridge, solid-based next-generation staining and immunostaining(NGSI) stamping technology, and embedded artificial intelligence. Sample preprocessing, blood imaging, and reading functions are all performed within a miniaturized device, providing help in performing diagnostic tests in the field of blood and tissue cells in environments without large equipment or laboratories. In the report, Malaria Diagnostics Market and Technology Landscape 4th edition, Unitaid stated &#8216;the most advanced digital microscopes are fully integrated benchtop platforms from Noul&#8217;.<\/p>\n<p>miLab\u2122 is used at Korea Disease Control and Prevention Agency, Carlos III Health Institute in <span class=\"xn-location\">Spain<\/span>, the National Center for Malaria &amp; Vector Control in United Arab Emirate and Boston Chldren&#8217;s Hospital in the U.S. Based on these references, miLab\u2122&#8217;s use is rapidly increasing in African countries with malaria.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aim to accelerate global business and access to the public market based on reliable research results Grant funds will be utilized for global clinical studies and cost-effectiveness analysis of the miLab\u2122&nbsp;Platform over the next three years YONGIN, South Korea, March 27, 2023 \/PRNewswire\/ &#8212; Noul Co. Ltd (CEO : David Lim) announced that it has [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-17201","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=17201\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control - My Blog\" \/>\n<meta property=\"og:description\" content=\"Aim to accelerate global business and access to the public market based on reliable research results Grant funds will be utilized for global clinical studies and cost-effectiveness analysis of the miLab\u2122&nbsp;Platform over the next three years YONGIN, South Korea, March 27, 2023 \/PRNewswire\/ &#8212; Noul Co. Ltd (CEO : David Lim) announced that it has [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=17201\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T13:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/1854227\/Noul_logo1_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Noul Co. Ltd &#8211; The RIGHT Foundation Commences Research and Development for Supporting Malaria Control\",\"datePublished\":\"2023-03-27T13:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201\"},\"wordCount\":584,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/1854227\\\/Noul_logo1_Logo.jpg?p=medium600\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201\",\"name\":\"Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/1854227\\\/Noul_logo1_Logo.jpg?p=medium600\",\"datePublished\":\"2023-03-27T13:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/1854227\\\/Noul_logo1_Logo.jpg?p=medium600\",\"contentUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/1854227\\\/Noul_logo1_Logo.jpg?p=medium600\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=17201#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Noul Co. Ltd &#8211; The RIGHT Foundation Commences Research and Development for Supporting Malaria Control\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=17201","og_locale":"en_US","og_type":"article","og_title":"Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control - My Blog","og_description":"Aim to accelerate global business and access to the public market based on reliable research results Grant funds will be utilized for global clinical studies and cost-effectiveness analysis of the miLab\u2122&nbsp;Platform over the next three years YONGIN, South Korea, March 27, 2023 \/PRNewswire\/ &#8212; Noul Co. Ltd (CEO : David Lim) announced that it has [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=17201","og_site_name":"My Blog","article_published_time":"2023-03-27T13:00:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/1854227\/Noul_logo1_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=17201#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=17201"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Noul Co. Ltd &#8211; The RIGHT Foundation Commences Research and Development for Supporting Malaria Control","datePublished":"2023-03-27T13:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=17201"},"wordCount":584,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=17201#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/1854227\/Noul_logo1_Logo.jpg?p=medium600","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=17201","url":"https:\/\/transmediavictoria.net.au\/?p=17201","name":"Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=17201#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=17201#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/1854227\/Noul_logo1_Logo.jpg?p=medium600","datePublished":"2023-03-27T13:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=17201#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=17201"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=17201#primaryimage","url":"https:\/\/mma.prnasia.com\/media2\/1854227\/Noul_logo1_Logo.jpg?p=medium600","contentUrl":"https:\/\/mma.prnasia.com\/media2\/1854227\/Noul_logo1_Logo.jpg?p=medium600"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=17201#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Noul Co. Ltd &#8211; The RIGHT Foundation Commences Research and Development for Supporting Malaria Control"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/17201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17201"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/17201\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}